Skip to content
Recall Observatory FDA recall evidence

Drug product

Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60

D-0774-2022

April 07, 2022

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc
Event
Event 89910
Status
Terminated
Classification
Class II
Quantity
33,893 vials
Official record key
drug-enforcement:D-0774-2022

Official wording

Reason: Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

Code information: Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification